Bead-Based HPV Detection via Flow Cytometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for infectious diseases, such as those for Human Papilloma Virus (HPV), are time-consuming, labor-intensive, and often cannot differentiate between high-risk and low-risk strains, leading to inefficiencies and inaccuracies in cervical cancer detection.
Innovation Solution
A bead-based assay system that uses subsets of beads, each homogeneous in size but with reactants labeled differently for HPV strains, allowing for differentiation through flow cytometry based on size and fluorescent intensity, enabling rapid and accurate identification of HPV strains.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional diagnostic methods (Pap smear) are used for HPV detection, then the procedure is simple and widely available, but the false negative rate is high (approximately 20%) and the technique cannot distinguish between high-risk and low-risk strains
Solution Approach 1:
The assay is segmented into distinct functional components: microbeads with capture probes, fluorescently labeled detection probes, and flow cytometry analysis. This segmentation allows each component to perform its specific function optimally, achieving high detection accuracy while maintaining manageable overall complexity through modular design
Solution Approach 2:
Different regions of the assay system have specialized properties: microbeads provide high-affinity capture, fluorescent probes provide specific detection, and flow cytometry provides precise measurement. This local optimization of quality in different parts of the system enables superior overall performance without requiring uniform complexity throughout
2Adaptability or versatility
If existing diagnostic tests are used for infectious diseases, then they are specific for only one specific pathogen, but they require separate tests for different pathogens increasing time and labor
Solution Approach 1:
The flow cytometry-based assay platform serves multiple functions: it can detect different HPV strains simultaneously, distinguish between high-risk and low-risk types, and potentially detect other pathogens with appropriate probe selection. This multi-functionality eliminates the need for separate tests for different pathogens, dramatically improving screening productivity
3Reliability
If existing diagnostic tests are used for infectious diseases, then they can detect specific pathogens, but they are time-consuming and labor-intensive
Solution Approach 1:
The assay replaces manual, labor-intensive diagnostic procedures with automated flow cytometry analysis. The mechanical automation of sample processing, probe hybridization, and data analysis eliminates human labor requirements while maintaining high detection reliability through standardized protocols and objective measurement
Solution Approach 2:
The assay enables continuous processing of multiple samples through automated flow cytometry, eliminating idle time between tests. Samples can be processed in sequence without interruption, and the system maintains readiness for immediate analysis, dramatically reducing total testing time while preserving detection reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for rapid and inexpensive detection and differentiation of HPV strains, improving the accuracy of cervical cancer risk assessment and reducing false negatives, enabling more effective screening for cervical cancer.
Implementation Method 1
the subset identity and therefore the reactant to which the bead has been coupled is identifiable by flow cytometry based on size, fluorescent intensity and analyte discrimination
Implementation Method 2
the reactant on each bead is labeled with the same label with each subset of beads having a different fluorescent intensity
Data Source
AI summary
The present invention relates generally to the field of diagnostic and detection assays. More particularly, the present invention provides methods, and reagents including biochips for detecting the presence of, or distinguishing between, one or more analytes in a sample.